Format

Send to

Choose Destination
Bioinformatics. 2009 Nov 1;25(21):2809-15. doi: 10.1093/bioinformatics/btp505. Epub 2009 Aug 19.

Quantifying cancer progression with conjunctive Bayesian networks.

Author information

1
Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland. moritz.gerstung@bsse.ethz.ch

Abstract

MOTIVATION:

Cancer is an evolutionary process characterized by accumulating mutations. However, the precise timing and the order of genetic alterations that drive tumor progression remain enigmatic.

RESULTS:

We present a specific probabilistic graphical model for the accumulation of mutations and their interdependencies. The Bayesian network models cancer progression by an explicit unobservable accumulation process in time that is separated from the observable but error-prone detection of mutations. Model parameters are estimated by an Expectation-Maximization algorithm and the underlying interaction graph is obtained by a simulated annealing procedure. Applying this method to cytogenetic data for different cancer types, we find multiple complex oncogenetic pathways deviating substantially from simplified models, such as linear pathways or trees. We further demonstrate how the inferred progression dynamics can be used to improve genetics-based survival predictions which could support diagnostics and prognosis.

AVAILABILITY:

The software package ct-cbn is available under a GPL license on the web site cbg.ethz.ch/software/ct-cbn

CONTACT:

moritz.gerstung@bsse.ethz.ch.

PMID:
19692554
PMCID:
PMC2781752
DOI:
10.1093/bioinformatics/btp505
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center